Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions

Inflamm Res. 2009 Oct;58(10):659-68. doi: 10.1007/s00011-009-0031-9. Epub 2009 Mar 31.

Abstract

Objective and design: Insulin resistant Otsuka-Long-Evans-Tokushima Fatty (OLETF) and its control Long-Evans Tokushima Ohtsuka (LETO) rats were used to generate a model for acute hyperuricemia. Upon the onset of insulin resistance OLETF rats were feed with high-purine diet, and the development of acute hyperuricemic renal injury and gouty-like lesions was monitored. Rosiglitazone was also administered to demonstrate whether improved insulin sensitivity would prevent high-purine diet induced renal injury and gouty-like lesions.

Results: Otsuka-Long-Evans-Tokushima Fatty rats showed significant higher incidence of hyperuricemia as compared to the control LETO rats (77 vs. 36.1%, P < 0.05), indicating that insulin resistance exacerbates the development of hyperuricemia following high-purine load. Consistent with this observation, improvement of insulin sensitivity by administration of rosiglitazone significantly reduced high-purine diet induced renal injury and gouty-like lesions. It was found that insulin resistance is associated with impaired capability for maintaining the homeostasis of renal uric acid excretion and reabsorption. Upon high-purine load, insulin resistance enhances urate reabsorption as manifested by up-regulated URAT1 expression and reduces urate excretion as characterized by down-regulated UAT expression.

Conclusions: Our data demonstrated strong evidence indicating that insulin resistance acts as an independent risk factor predisposing OLETF rats more susceptible to the development of hyperuricemia and gouty arthritis following high-purine load.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / physiopathology
  • Disease Models, Animal
  • Gout / chemically induced*
  • Gout / physiopathology*
  • Gout / prevention & control
  • Homeostasis / physiology
  • Hyperuricemia / chemically induced*
  • Hyperuricemia / physiopathology*
  • Hyperuricemia / prevention & control
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance / physiology*
  • Knee Joint / physiopathology
  • Male
  • Obesity / complications
  • Obesity / physiopathology
  • Organic Anion Transport Protein 1
  • Organic Anion Transporters / metabolism
  • Organic Anion Transporters, Sodium-Independent / metabolism
  • Purines / adverse effects*
  • Rats
  • Rats, Inbred OLETF
  • Risk Factors
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use
  • Uric Acid / metabolism

Substances

  • Hypoglycemic Agents
  • Organic Anion Transport Protein 1
  • Organic Anion Transporters
  • Organic Anion Transporters, Sodium-Independent
  • Purines
  • Slc22a6 protein, rat
  • Thiazolidinediones
  • organic anion transport protein 3
  • urate transporter
  • Rosiglitazone
  • Uric Acid